Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa.
Anorexia nervosa and bulimia nervosa remain enigmatic disorders with poorly understood etiologies. Clinicians continue to find these disorders very challenging to treat. As their underlying pathophysiology is clarified, it is hoped that specific pharmacologic treatments will be developed to alleviate the pain and disability these disorders produce.
Hoffman
L
L
New York Hospital-Westchester Division, Cornell University Medical Center, White Plains.
Halmi
K
K
D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000523:psychology; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002032:Bulimia / Q000188:drug therapy* / Q000523:psychology; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D015430:Weight Gain / Q000187:drug effects
D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D016651:Lithium Carbonate